Differentiation, Proliferation and Adhesion of Human Neuroblastoma Cells After Treatment with Retinoic Acid

References

• Abemayor E., Sidell N. Human neuroblastoma cell lines as models for the in vitro study of neoplastic and neuronal cell differentiation. Environ. Health Perspect. 1989; 80: 3–15
   PubMed Web of Science ®Google Scholar
• Adem A., Mattson M. E., Nordberg A., Pahlman S. Muscarinic receptors in human SH-SY5Y neuroblastoma cell line: regulation by phorbol ester and retinoic acid-induced differentiation. Brain Res. 1987; 430: 235–242
   PubMed Web of Science ®Google Scholar
• Barletta E., Mugnai G., Ruggieri S. Inverse relationship between invasiveness and differentiative capacity in different human neuroblastoma cell lines. Int. J. Cancer 1997; 70: 556–560
   PubMed Web of Science ®Google Scholar
• Barnstable C. J. Identification of cell types in neural cultures. Neuromelhods, Vol. 23: Practical Cell Culture Techniques., A. Boulton, G. Baker, W. Walz. The Humana Press Inc., New York 1992; 21–62
   Google Scholar
• Berger R., Albelda S. M., Berd D., Ioffreda M., Whitaker D., Murphy G. F. Expression of platelet-endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo. J. Cutan. Pathol. 1993; 20: 399–406
   PubMed Web of Science ®Google Scholar
• Biedler J. L., Spengler B. A., Chang T., Ross R. A. Tran,sdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. Advances in Neuroblastoma Research 2., A. E. Evans, J. L. Biedler, G. M. Brodeur, G. J. D'Angio, A. Nakagawara. Wiley-Liss, New York 1988; 265–777
   Google Scholar
• Brodeur G. M., Nakagawara A. Molecular basis of clinical heterogeneity in neuroblastoma. Am. J. Pediatr. Hematol. Oncol. 1992; 14: 111–116
   PubMedGoogle Scholar
• Bouillon M., Tessier P., Boulianne R., Destrempc R., Audette M. Regulation by retinoic acid of ICAM-1 expression on human tumor cell lines. Biochim. Biophvs. Ada 1991; 1097: 95–102
   PubMed Web of Science ®Google Scholar
• Bussemakers M. J., Schalken J. A. The role of cell adhesion molecules and proteases in tumor invasion and metastasis. World J. Urol. 1996; 14: 151–156
   PubMed Web of Science ®Google Scholar
• Ciccarone V., Spengler B. A., Meyers M. B., Biedler J. L., Ross R. A. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 1989; 49: 219–225
   PubMed Web of Science ®Google Scholar
• Cohen P. S., Letterio J. J., Gaetano C., Chan J., Matsumoto K., Sporn M. B., Thiele C. J. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cancer Res. 1995; 55: 2380–2386
   PubMed Web of Science ®Google Scholar
• Dehner L. P., Abenoza P., Sibley R. K. Primary cerebral neuroectodermal tumors: neuroblastoma, differentiated neuroblastoma, and composite neuroectodermal tumor. Ultrastruct. Pathol. 1988; 12: 479–494
   PubMed Web of Science ®Google Scholar
• Edward M. Effect of retinoids on tumour invasion and metastasis. Pathobiology. 1992; 60: 271–277
   PubMed Web of Science ®Google Scholar
• Feyles V., Dixon W. T., Sikora L. K.J., McGarry R. C., Jerry M. Human melanoma-associated antigen expression on human neuroblastoma cells: effects of differentiation inducers. Cancer Immunol. Immunother. 1991; 32: 261–272
   PubMed Web of Science ®Google Scholar
• Garofalo A., Chirivi R. G.S., Scanziani E., Mayo J. G., Vecchi A., Glavazzi R. Comparative study on metastatic behavior of human tumors in nude, beige/nude/ xid and severe combined immunodeficient mice. Invasion Metastasis 1993; 13: 82–91
   PubMedGoogle Scholar
• Glick A. B., McCune B. K., Abdulkarem N., Flanders K. C., Lumadue J. A., Smith J. M., Sporn M. B. Complex regulation of TGF beta expression by retinoic acid in the vitamin A-deficient rat. Development 1991; 111: 1081–1086
   PubMed Web of Science ®Google Scholar
• Goldberger A., Middleton K. A., Newman P. J. Changes in expression of the cell adhesion molecule PECAM-1 (CD31) during differentiation of human leukemic cell lines. Tissue Antigens 1994; 44: 285–293
   PubMed Web of Science ®Google Scholar
• Gudas L. J., Sporn M. B., Roberts A. B. Cellular biology and biochemistry of the retinoids. The Retinoids: Biology. Chemistry, and Medicine., M. B. Sporn, A. B. Roberts, D. S. Goodmann. Raven Press, New York 1994; 443–520
   Google Scholar
• Hakamori S. Tumor malignancy defined by aberrant glycosylation and sphingoglycolipid metabolism. Cancer Res. 1996; 56: 5309–5318
   PubMed Web of Science ®Google Scholar
• Hartley C. L., Johnston H. B., Nicol S., Chan K. M., Baines A. J., Anderton B. H., Thomas S. M. Phenotypic morphology and the expression of cytoskeletal markers during long-term differentiation of human SH-SY5Y neuroblastoma cells. Toxicol. In Vitro 1996; 10: 539–550
   PubMed Web of Science ®Google Scholar
• Heavner G. A. Active sequences in cell adhesion molecules: targets for therapeutic intervention. Drug Discovery Today 1996; 1: 295–304
   Web of Science ®Google Scholar
• Herpers M. J., Budka H. Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma (“arachnoidal sarcoma of the cerebellum”). Clin. Neuropathol. 1985; 4: 12–18
   PubMed Web of Science ®Google Scholar
• Hunt N. C., Douglas-Jones A. G., Morgan J. M., Pignatelli M. Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas. Virchows Arch. 1997; 430: 285–289
   PubMed Web of Science ®Google Scholar
• Khan A. A., Villablanca J. G., Reynolds C. P., Avramis V. I. Pharmacokinetic studies of 13-cz.s-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation. Cancer Chemother. Pharmacol. 1996; 39: 34–41
   PubMed Web of Science ®Google Scholar
• Lovat P. E., Irving H., Annicchiarico-Petruzzelli M., Bernassola F., Malcolm A. J., Pearson A. D.J., Melino G., Redfern C. P.F. Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-trans-retinoic acid. Eur. J. Cancer 1997; 12: 2075–2080
   Web of Science ®Google Scholar
• Matsumoto K., Gaetano C., Daughaday W. H., Thiele C. J. Retinoic acid regulates insulin-like growth factor II expression in a neuroblastoma cell line. Endocrinology 1992; 130: 3669–3676
   PubMed Web of Science ®Google Scholar
• Melino G. Discussion: differentiation I. Advances in Neuroblastoma Research 4., A. E. Evans, J. L. Biedler, G. M. Brodeur, G. J. D'Angio, A. Nakagawara. Wiley-Liss., New York 1994; 215
   Google Scholar
• Morton A. J., Hammond C., Mason W. T., Henderson G. Characterisation of the L- and N-type calcium channels in differentiated SH-SY5Y neuroblastoma cells: calcium imaging and single channel recording. Brain Res. Mol. Brain Res. 1992; 13: 53–61
   PubMedGoogle Scholar
• Piacentini M., Annicchiarico-Petruzzelli M., Oliverio S., Piredda L., Biedler J. L., Melino E. Phenotype-specific “tissue” transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int. J. Cancer 1992; 52: 271–278
   PubMed Web of Science ®Google Scholar
• Piacentini M., Fesus L., Melino G. Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells. EEBS Lett. 1993; 320: 150–154
   PubMed Web of Science ®Google Scholar
• Ponzoni M., Bocca P., Chiesa V., Decensi A., Pistoia V., Raffaghello L., Rozzo C., Montaldo P. G. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Cancer Res. 1995; 55: 853–861
   PubMed Web of Science ®Google Scholar
• Rosati R., Ramnath N., Adil M. R., Ou X., Ali M. A., Heyman R. A., Kalemkerian G. P. Activity of 9-m-retinoic acid and receptor-selective retinoids in small cell lung cancer cell lines. Anticancer Res. 1998; 18: 4071–4075
   PubMed Web of Science ®Google Scholar
• Ross R. A., Spengler B. A., Biedler J. L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 1983; 71: 741–747
   PubMed Web of Science ®Google Scholar
• Ross R. A., Spengler B. A., Rettig W. J., Biedler J. L. Differentiation-inducing agents stably convert human neuroblastoma I-type cells to neuroblastic (N) or non-neuronal (S) neural crest cells. Advances in Neuroblastoma Research 4., A. E. Evans, J. L. Biedler, G. M. Brodeur, G. J. D'Angio, A. Nakagawara. Wiley-Liss, New York 1994; 253–259
   Google Scholar
• Ross R. A., Spengler B. A., Domenech C., Porubcin M., Rettig W. J., Biedler J. L. Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Diff. 1995; 6: 449–456
   PubMedGoogle Scholar
• Rozzo C., Chiesa V., Ponzoni M. Integrin up-regulation as a marker of neuroblastoma cell differentiation: correlation with neurite extension. Cell Death Diff. 1997; 4: 713–724
   PubMed Web of Science ®Google Scholar
• Schwechheimer K. Neural tumor markers. Verh. Dtsch. Ges. Pathol. 1986; 70: 82–103
   PubMedGoogle Scholar
• Shapiro S. S., Poon J. P. Retinoic acid-induced alterations of growth and morphology in an established epithelial line. Exp. Cell Res. 1979; 119: 349–357
   PubMed Web of Science ®Google Scholar
• Streit M., Schmidt R., Hilgenfeld R. U., Thiel E., Kreuser E. D. Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors. J. Mol. Med. 1996; 74: 253–268
   PubMed Web of Science ®Google Scholar
• Villablanca J. G., Khan A. A., Avramis V. I., Seeger R. C., Matthey K. K., Ramsay N. K., Reynolds C. P. Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation. J. Clin. Oncol. 1995; 13: 894–901
   PubMed Web of Science ®Google Scholar
• Voigt A., Hafer R., Zintl F. Monoclonal antibodies against neuroblastoma. Production and preliminary characterization of their specificity. J. Neuroimmunol. 1993; 43: 125–130
   PubMed Web of Science ®Google Scholar
• Voigt A., Hiifer R., Gruhn B., Zintl F. Expression of CD34 and other haematopoietic antigens on neuroblastoma cells: consequences for autologous bone marrow and peripheral blood stem cell transplantation. J. Neuroimmunol. 1997a; 78: 117–126
   PubMed Web of Science ®Google Scholar
• Voigt A., Berndt A., Lauterbach H., Carlsohn H., Hiiller M., Stiller K. J., Gottschild D., Zintl F. Radio-immunodetection of neuroblastoma cells with 1-131-radiolabelled antibodies. Cancer Biother. Radiopharm. 1997b; 12: 187–194
   PubMed Web of Science ®Google Scholar
• Wada R. K., Pai P. S., Huang J., Yamashiro J. M., Sidell N. Interferon-gamma and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action. Cancer Lett. 1997; 121: 181–188
   PubMed Web of Science ®Google Scholar